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Typing and Whole-genome Sequencing of Brucella isolated from Clinical 
Samples in Lebanon 
 
Natalia Abou Zaki 
 
ABSTRACT 
Brucella is a Gram-negative intracellular bacterium that causes brucellosis characterized 
by several symptoms including fever, nausea and myalgia. Routes of infection include 
direct contact through skin or mucous membranes, inhalation, handling manure of 
infected animals and ingestion of infected dairy products. Brucella melitensis is the main 
causative agent of infection in Lebanon, with increasing incidence as a result of 
occupational contact and ingestion of infected meat and dairy products. Whole-genome 
sequencing (WGS) is essential for pathogenomics and evolutionary analysis of different 
species of Brucella. In this study, and as a follow-up to previous studies done in 
Lebanon, resistance profiles to common antibiotics used against Brucella by antibiotic 
disc diffusion method were obtained. The isolates were shown to be resistant to 
fluoroquinolones and co-trimoxazole. Typing of Brucella was performed using 16S 
rRNA sequencing, Bruce-ladder multiplex PCR, and PCR-RFLP of omp2a and omp31 
genes.  16S rRNA sequencing confirmed the genus Brucella, while PCR-RFLP of 
omp31 and omp2a proved more accurate and practical in detecting the species than 
viii 
 
Bruce-ladder PCR.  Sixteen isolates were chosen for WGS and their subsequent 
genomes were analyzed for presence of virulence and resistance determinants, genomic 
islands, CRISPRs, prophages, insertion sequences and phylogenetic analysis. Several 
virulence genes vital for Brucella pathogenicity were detected in our isolates including 
type IV secretion system, flagellar and LPS genes, ureases and BvrR/S two component 
system. Additionally, antibiotic resistance genes against quinolones and efflux pumps 
mediating multidrug efflux were also found, indicating the emerging resistance patterns 
in Lebanon. Prophages, insertion sequences and genomic islands confirmed that lateral 
gene transfer occurred in our B. melitensis strains and further contributed to the genome 
evolution, diversity, and virulence. To our best knowledge, this is the first kind of study 
done on Brucella in Lebanon. It will provide an insight into brucellosis and its 
prevalence in addition to highlighting the importance of taking control measures to limit 
future spread of the disease.  
Keywords: Brucella, Brucella melitensis, Brucellosis, Bruce Ladder, PCR-RFLP, 
Whole-genome sequencing, WGS, Virulence determinants 
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Chapter One 
INTRODUCTION 
Brucella is a Gram-negative, facultative intracellular bacterium belonging to α- 
proteobacteria (Moreno et al., 2002). They lack endospores, native plasmids, flagella, 
capsules and other classical virulence factors (Moreno et al., 2002). The twelve Brucella 
species are: B. abortus, B. suis, B. ovis, B. melitensis, B. canis, B. neotomae, B. 
pinnipedialis, B. ceti, B. microti and B. inopinata (Galinska & Zagόrski, 2013), with two 
species recently discovered: B. papionis and B. vulpis (Scholz et al., 2016; Whatmore et 
al., 2014). Out of these, B. melitensis, B. suis and B. abortus mainly cause human 
infections, with some cases of B. canis infections (Wang et al., 2014). B. abortus causes 
the mildest form of brucellosis in humans, B. suis causes a more severe form, and the 
most pathogenic is B. melitensis (Wang et al., 2014). There is a high degree of genetic 
similarity between the different species as seen by DNA-DNA hybridization tests (Tiller 
et al., 2010).  
Brucellosis is a zoonotic disease (Buzgan et al., 2010). The routes of transmission could 
be through consumption of infected meat, ingestion of raw dairy products or direct 
contact with animals carrying the disease (Buzgan et al., 2010). Animals that are 
infected with Brucella excrete the bacterium through body fluids including milk, sperm, 
urine and vaginal secretions (Xu et al., 2013). In the case of fetus abortion in animals 
such as cattle, Brucella is also excreted in amniotic fluid (Xu et al., 2013). Symptoms of 
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brucellosis include: fever, nausea, myalgia, arthralgia of large joints, headache, chills, 
malaise, and sweating (Fanni et al., 2013).  
The disease is difficult to treat and its complexity resides in the fact that it is associated 
with bacteremia, toxemia, and allergy, in addition to the organism being able to invade 
many organs, and impenetrability of infected cells to antimicrobial agents (Ko & 
Splitter, 2003; Oliveira et al., 2010). The clinical forms of the disease could be acute, 
sub-acute, chronic, relapsed, non-active or active (Wang et al., 2014). Because of the 
nonspecific nature of the disease, diagnosis and confirmation with laboratory testing is a 
must (Wang et al., 2014). Antibiotic administration however, could cause and depending 
on the patient, relapses and treatment failure (Ariza et al., 2007). Hydrogen sulfide (H2S) 
production, requirement of CO2 or urease test can all be used to confirm the species after 
its isolation from blood, tissue specimens and body fluids (Al Dahouk et al., 2013). On 
the other hand, serological tests targeting specific Brucella antibodies in the host, or 
PCR based assays for detection of Brucella DNA can also be used (Sakran et al., 2006). 
Several drawbacks are associated with the isolation of Brucella species including the 
health hazard it presents to laboratory staff and time consumption (Pabuccuoglu et al., 
2011). Serological tests work better with the risk of producing false positive results due 
to cross reactivity (Pabuccuoglu et al., 2011).  
Regulatory programs have been implemented for the consequent eradication of 
brucellosis due to its prevalence in humans and in animals. These programs include 
vaccinations and sanitization procedures (Olsen & Stoffregen, 2005). Sanitization 
programs aim at implementing producers for decontamination and for the proper 
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discharge of contaminated material to decrease the dissemination of the infectious agent 
(Avila-Calderόn et al., 2013).  
Brucella pathogenesis lies in its ability to survive intracellularly and multiply within 
professional and non-professional phagocytic cells through lipopolysaccharides (LPS) 
and T4SS, which are thought to play a role in enhancing its virulence and aid in host 
evasion (Ben-Tekaya et al., 2013). Two phases constitute the Brucella lifecycle: acute 
infection which occurs in non-phagocytic cells and leads to abortion in animals, and 
chronic infection which happens in phagocytic cells leading to replication of the 
bacterium and its subsequent survival in the host (Yongqun, 2012). Lymph nodes, sex 
organs, spleen, liver, and bone marrow are all organs that can be affected by brucellosis 
and transmission to different organs and systems occurs via macrophages (Ko & Splitter, 
2003). 
Humoral immunity and production of antibodies by the host against the O-antigen on the 
LPS of the bacterium provides only partial protection, while cell mediated immunity is 
the main mode of defense used by the host against Brucella infection (Yongqun, 2012).  
In Lebanon, brucellosis is mainly caused by B. melitensis (Araj & Azzam, 1996; Dajani 
et al., 1989) with a reported increase in disease incidence following contamination of 
meat and dairy products in addition to occupational risk (Young, 1991). Hence, the 
increase in the importance of studying this organism in order to better understand its 
mechanisms of infection and hopefully limit and control its spread in the future (Araj & 
Azzam, 1996) 
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Thirty-three Brucella isolates provided by Azm Center for Research and Biotechnology 
recovered mainly from blood, with only two from ascitic and synovial fluids were used 
in this study to (i) examine the population dynamics of pathogenic Brucella strains, (ii) 
sequence the 16S rRNA gene in order to identify Brucella on the genus-level and its 
differentiation from organisms which are closely related to it, (iii) type the isolates by 
Bruce Ladder multiplex PCR to discriminate between different species, (iv) identify the 
isolates' biotypes and biovars and determine DNA polymorphism from the restriction 
patterns through PCR-RFLP of omp31 and omp2a genes, (v) study the functional 
genomics through whole-genome sequencing (WGS) of sixteen representative isolates, 
(vi) identify genes related to host adaptation and investigate variation in virulence 
potential in order to estimate the fitness of these pathogens, (vii) correlation between the 
virulence factors detected such as type IV secretion system, BvrR/S two component 
system, LPS- related genes, ureases and subsequent pathogenicity of Brucella, (viii) 
prediction and annotation of the components of the T4SS in Brucella spp. using the 
sixteen complete genomes and determine the physical and functional interactions 
between the corresponding proteins, (ix) screening the genomes for pathogenicity 
islands,  clustered regularly interspaced short palindromic repeats (CRISPRs), and phage 
related proteins and correlate their role in virulence and resistance, (x) characterize the 
insertion sequences across the Brucella genomes and evaluate their roles, (xi) determine 
phylogenetic groups of isolated Brucella, and use genome data to construct a 
phylogenetic tree, (xii) and perform a comparative analysis of the genes present in the 
different phylogenetic groups.   
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Chapter Two 
LITERATURE REVIEW 
2.1. Brucella: An Overview 
Brucellosis is a zoonotic disease that is caused by small aerobic Gram-negative bacteria 
that penetrate and proliferate in the lymphatic system before subsequently disseminating 
to various organs of the body causing infection in different tissues (Smits, & Kadri, 
2005). B. melitensis, is the most pathogenic and was first isolated in Malta in 1887 
(Galinska & Zagorski, 2013), B. abortus is associated with infections in cattle and 
humans (Kang et al., 2011), B. suis is linked to brucellosis in humans as well as swine 
(Kang et al., 2011), B. canis causes disease in dogs and possibly infections in humans 
(Iwaniak et al., 1999), B. neotomae infects rats (Szulowski, & Murat, 2008), B. ovis 
infects sheep and rams (Boryczko et al., 1985), B. ceti and B. pinnipedialis were isolated 
from whales and seals and other ocean mammals (Bricker et al., 2000; Tryland et al., 
1999), B. microti was isolated from lymphatic systems of wild foxes and common vole 
(Scholz et al., 2009), and B. inopinata from breast implant of a woman that had 
brucellosis clinical signs (Scholz et al., 2010). Additionally, B. papionis, which was 
isolated in 2007 by Schlabritz-Loutsevitch et al., is a coccobacilli or short rod, non-
motile, non-spore forming and aerobic. It is resistant to doxycycline, rifampicin, 
ciprofloxacin and streptomycin, and is catalase and urease positive in addition to being 
oxidase negative. It doesn’t require CO2 for growth and doesn’t produce H2S 
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(Schlabritz-Loutsevitch et al., 2009; Whatmore et al., 2014). A PCR assay (AMOS: 
abortus, melitensis, ovis, suis) can be used to confirm the Brucella genus through 
generating a specific amplicon of 180 base pairs (bp) (Schlabritz-Loutsevitch et al., 
2009), however upon the application of Bruce-ladder PCR, RFLP on outer membrane 
protein 2 (omp2), and Multiple Locus Variable-number Tandem Repeat Analysis 
(MLVA) on B. papionis, the species was not identified (Whatmore et al., 2014).  
Recently, Scholz et al. 2016 reported a new species of Brucella, named B. vulpis that 
was isolated from lymph nodes of red foxes and didn’t fit the criteria of other species. 
Interestingly, 5% of the genome was attributed to non-Brucella origin, containing 
phages and insertion sequences that were not characterized yet in Brucella, and 
phylogenetic analysis showed that it was separated from other species and found in a 
distinct clade (Scholz et al., 2016).  
2.2. Forms and Symptoms of Brucellosis  
Since brucellosis affects many organs/systems, the clinical manifestations of the disease 
are very broad (Jiao et al., 2015). Abortion and sterility in animals is seen as a result of 
infection (Hashino et al., 2012). Clinical polymorphism of brucellosis causes difficulty 
in diagnosis and treatment, which leads to relapses, complications and misdiagnosis 
(Doganay et al., 2008; Young, 2005). 
Chronic brucellosis is characterized by depression, emotional liability, and 
musculoskeletal pain such as: arthralgias, myalgia, and arthritis in addition to 
nervousness, malaise and a positive rheumatoid factor test (Colmenero et al., 2007; 
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Young 2005). On the other hand, clinical laboratory results in patients with acute and 
sub-acute forms include leukopenia, anemia, increased levels of C-Reactive Protein 
(CRP), elevated levels of liver enzymes and thrombocytopenia, high erythrocyte 
sedimentation rate, and high levels of monocytes and lymphocytes (Buzgan et al., 2010). 
Gastrointestinal, hematological, cardiovascular, central nervous system and respiratory 
are all systems that can be affected by the disease (Shapiro et al., 1999). 
Lymphadenopathy, which is not common to brucellosis, can only be seen in severe cases 
of the disease (Pappas et al., 2005). Severity of the disease is highly linked to the 
immune response especially the cell mediated, which is mostly involved in protection 
against brucellosis (Cannella et al., 2012).  
2.3. Brucellosis Routes of Infection 
Wild animals, rodents, cattle, sheep, and goats can all constitute a vector and a reservoir 
for the disease in humans since Brucella affects many animals including domesticated 
and wild, rodents and marine mammals (Godfroid et al., 2005). Incidence of brucellosis 
is highly related to occupation and the most susceptible individuals are the ones working 
in farms, meat processing enterprises, veterinary doctors, and zoo technicians (Galinska 
& Zagorski, 2013). Brucella can be transmitted by direct contact through breaks in skin 
and mucosal membranes (Corbel, 1997) or indirectly through the oral fecal route (Zhang 
et al., 2014). Inhalation of droplets from laboratory samples during specimen handling 
for laboratory technicians or inhalation as a result of close contact with infected animals 
also constitutes a common route of infection (Godfroid et al., 2005). Brucellosis could 
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also be transmitted through ingestion of food (meat, unpasteurized milk, or dairy 
products) as well as contaminated water (Ismayilova et al., 2013). Brucella is very 
potent and can survive 60 days in dairy products or meat and up to 120 days in soil and 
150 in water (Jiao et al., 2009).  
2.4. Pathogenesis and Virulence of Brucella 
Brucella can evade the host immune response and invade cells to multiply either in the 
vacuole or in the cytoplasm (Gomez et al., 2013a). It uses fibronectin, vitronectin and 
SP41, which is a 41-kDa protein on its surface encoded by ugpB locus, to bind to 
receptors on surfaces and penetrate epithelial, phagocytic and non-phagocytic cells of 
mucosal membranes (Billard et al., 2005; Castaneda-Roldan et al., 2004; Kim et al., 
2004).  
Additionally, its LPS is composed of lipid A, O-antigen, and core oligosaccharide 
(Lapaque et al., 2005). LPS plays an important role in internalization of Brucella 
through interaction with lipid rafts, and Fc and complement receptors on the surface of 
host cells (Moreno & Moriyon, 2002). It also aids in evading the host immune response 
by protecting it from the complement cascade (Lapaque et al., 2006). As many other 
Gram-negative bacteria, Brucella grows as smooth or rough colonies, which depends on 
its LPS composition: smooth strains possess the O-antigen while rough strains lack it 
(Mancilla, 2015). The O-antigen has been classified as a virulence factor of Brucella, 
and hence rough Brucella strains are usually more attenuated (Pei & Ficht, 2004). 
Smooth strains however, are internalized at a lower rate than the rough ones although 
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they are more pathogenic, mainly because the uptake of smooth strains is through lipid 
raft dependent mechanisms, while rough strains are internalized by both lipid raft 
dependent and independent mechanisms (Gomez et al., 2013a; Jimenez de Bague et al., 
2004). Lipid raft mediated uptake of Brucella involves two types of receptors: cellular 
prion protein (PrPC) and class A scavenger receptor (Kim et al., 2004). 
Another system highly involved in internalization of Brucella is the BvrRS TCS, which 
is a two component regulatory system made of a histidine kinase sensor (BvrS) and 
cytoplasmic regulator (BvrR), involved in the control of structure of LPS and 
periplasmic protein expression thereby leading to the expression of outer membrane 
protein 22 (Omp22) and outer membrane protein 25 (Omp25) (Guzman-Verri et al., 
2002; Manterola et al., 2007). A deletion of BvrRS TCS system in Brucella leads to 
altered uptake of the organism by host cells, in addition to attenuated virulence of 
Brucella and failure of the organism to replicate inside the host cell (Figueiredo et al., 
2015). 
On the other hand, the organism protects itself inside the host cell from bactericidal 
agents and harsh conditions such as lysozyme production. It does so by: the up 
regulation of virulence factors and structural components (Copin et al., 2012), and 
production of antigens, early endosome antigen 1 (EEA-1) and Rab5 antigens, following 
interaction with lysosomes and endosomes, which aid in Brucella internalization (Starr 
et al., 2008). For vacuole maturation, Brucella employs β-1,2-glucans that act through 
lipid raft control (Arellano-Reynoso et al., 2005). The Brucella-containing vacuole 
(BCV) then matures and expresses late endocytic markers such as lysosome-associated 
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membrane protein 1 (LAMP-1) and Rab7 (Boschiroli et al., 2002; Celli et al., 2005); a 
process through which T4SS encoded by virB operon is induced and activates effector 
proteins (Sieira et al., 2000). 
Acidification of BCV and interaction with endoplasmic reticulum (ER) components 
allows Brucella to acquire ER-specific markers and only then it can efficiently replicate 
in the host (Celli et al., 2005; von Bargen et al., 2012). Brucella internalization and 
intracellular trafficking steps in mammalian cells of the host are briefly described in 
Figure 1, where it shows the mechanism of internalization mainly for smooth strains 
(Gomez et al., 2013a). Certain virulence factors including T4SS, BvrRS TCS and 
Omp25 proteins are upregulated in the intracellular stage of infection (Wang et al., 
2009b). 
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Figure 1. Schematic representation of steps in Brucella internalization and intracellular 
trafficking (Gomez et al., 2013a). 
After internalization inside host cells, Brucella plays an important role in cell death by 
inhibiting apoptosis in monocytes and macrophages or by delaying apoptosis in 
lymphocytes in order to persist inside the host (Dornan et al., 2000; Hoover et al., 2003). 
This is mediated by the overexpression of anti-apoptotic proteins such as A1 of the Bcl-
2 family and under expression of pro-apoptotic factors such as caspase-3 (Dornand et al., 
2000). Other anti-apoptotic factors released by Brucella include outer membrane protein 
2b (Omp2b) and Omp25 porins that regulate tumor necrosis factor alpha (TNF-α) 
secretion (Gross et al., 2000). 
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T4SS secretion system also has an important role in cell death as it is one of the most 
important virulence factors in Brucella having several effector proteins and 11 
components (virB1-11) (Ke et al., 2015). Manipulation of vesicle trafficking in host 
cells, regulation of inflammatory response, inhibition of immune response, and 
enhancing intracellular survival in host cells are all ways through which T4SS enhances 
the virulence of Brucella (Ke et al., 2015). Its deletion leads to an increase in replication 
of host cells and a decrease in cytotoxic and cytopathic effects imposed on the cell as a 
result of Brucella infection (Ficht et al., 2008; Zhong et al., 2009). 
Other virulence factors include the TpcB protein that inhibits the cytotoxic function of 
T-cells and subsequently protects from the cell-mediated immune response in addition to 
inhibition of dendritic cells maturation (Durward et al., 2012; Salcedo et al., 2008). 
Proline racemase protein A (PrpA), a protein that modulates the host immune response, 
induces B lymphocytes to produce the immunosuppressive cytokine interleukin 10 (IL-
10), and serves as a virulence factor (Spera et al., 2006).  
Other than the intracellular lifestyle, multiple metal homeostasis systems are found in 
Brucella that enhance its virulence (Roop, 2012). These include nickel, cobalt, zinc, 
manganese, iron, and copper transport systems that consist of translational and 
regulatory elements in addition to efflux proteins (Roop, 2012).  Many metals play a role 
as cofactors that are needed for the activity of Brucella enzymes. Iron is needed for 
catalase and aldolase activity (Schroeder et. al, 2009), Brucella uses the oxygenase to 
break down heme to be used as a source of iron (Ojeda et al., 2012).  Manganese is 
required too, and MntH is a manganese transporter, the deletion of which leads to 
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attenuation of Brucella (Anderson et al., 2009). On the other hand, zinc is a cofactor for 
the enzymes carbonic anhydrase I and II and has been also shown to increase virulence 
(Andreini et al., 2006; Lopez et al., 2012). Magnesium has a double function: it is a 
cofactor for erythritol kinase (Sperry & Robertson, 1975) and it maintains the integrity 
of the cell membrane (structural role) in Brucella (Moomaw & Maguire, 2008). 
Altogether this data indicate that Brucella can withstand a metal deprived environment 
due to these metal homeostasis systems, that help in the acquisition of the needed 
amounts of metals and sustaining its viability in the host (Roop, 2012).  
2.5. Interaction with Host Immune System 
The main mode of protection of the body against Brucella is through activated 
macrophages, in addition to the development of cell-mediated immune response and T 
helper 1-type (Th1) immunity (Mantur et al., 2007). Innate immunity against Brucella is 
mediated by phagocytosis, cytokine production, recognition of pathogen-associated 
molecular patterns (PAMPS), chemokine production and through the triggering and 
activation of the complement cascade (Ahmed et al., 2016). It utilizes neutrophils to 
reach lymphoid tissues and through the process employs different mechanisms to protect 
it from lysozymes, phospholipases, and reactive oxygen species (Nathan & Shiloh, 
2000). Recognition of Brucella through Toll like receptors is down-regulated in the 
course of infection and is a mode by which the organism shields itself from host’s 
immune response (Iwasaki & Medzhitov, 2004). 
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Moreover, down regulation of TNF-α associated with production of Omp25 leads to 
impairment in the activation and function of natural killer cells (NK) (Jubier-Maurin et 
al., 2001; Mantur et al., 2007). NK cells are activated by IL-2 and in turn secrete 
interferon gamma (IFN-γ) in order to exert a Th1 response against Brucella infection 
(Gao et al., 2011). Brucella down regulates Th1 immune response through bypassing IL-
12 production (Salcedo et al., 2008), which leads to decreased maturation of dendritic 
cells and thus decreased antigen presentation to T cells (Salcedo et al., 2008).  
It also uses phosphoinositide 3-kinase (PI3-kinase) pathway to facilitate entry into 
dendritic cells while using lipid rafts to internalize macrophages (Pei et al., 2008). 
Moreover, a fatty acid residue in LPS of Brucella (C28) is longer than in other bacterial 
organisms and this decreases its endotoxic properties and helps it to evade recognition 
through toll-like receptor 4 (TLR4) (Lapaque et al., 2009). Additionally, C3 complement 
component has a reduced ability to bind to Brucella outer membrane surface during 
infection (Ahmed et al., 2016), whereas PrpA along with Brucella toll-like interacting 
proteins (Btp1/TpcB) and the organism’s special structured LPS will regulate the 
immune response by decreasing levels of IFN-γ and increasing levels of IL-10 (Wang et 
al., 2012). Btp1 also has roles in decreasing nuclear factor kappa B (NF-κB) production, 
blocking TLR2 and TLR4 signaling and pro-inflammatory cytokine production in 
addition to causing inhibition of CD8+ cytotoxic T-cell killing capacity (Radhakrishnan 
& Splitter, 2010; Salcedo et al., 2008).  
Humoral immunity does not play an effective role in the protection against Brucella, and 
antibodies are usually directed against Brucella LPS (Araya & Winter, 1990). 
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Antibodies do not protect against primary infection, but have a role in protection against 
re-infection (Casadevall & Pirofski, 2006). The role of antibodies is synergistic (Gomez 
et al., 2013b). 
Thus, Brucella interplays between innate and adaptive immune response and produces 
several effector molecules that will modulate the immune response helping it to 
successfully evade it (Ahmed et al., 2016).  
2.6. Diagnosis of Brucellosis 
The United States Centers for Disease Control and Prevention (US CDC) reports that 
Brucella can be diagnosed either by bacterial isolation from different clinical samples 
including cerebrospinal and joint fluid but mainly from blood cultures and through 
detection of antibodies against Brucella through Brucella microagglutination test 
(BMAT) (CDC, 2012). In chronic brucellosis however, false negative results in standard 
agglutination (SAT) or microagglutination tests (MAT) should be taken into 
consideration (Araj, 2010). 
Among the serological tests, the Rose Bengal agglutination test is very sensitive and is 
the method of choice for diagnosis in both humans and animals (Serra & Vinas, 2004). 
In order to confirm the result obtained by the Rose Bengal test, SAT and MAT tests are 
used, both having high specificity especially in the diagnosis of the acute form of 
brucellosis (Serra & Vinas, 2004). Enzyme-linked immunosorbent assay (ELISA) 
however, that can detect immunoglobulin G (IgG) and IgM antibodies against Brucella 
antigens, is sensitive but not specific so cannot be used to confirm the Rose Bengal 
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(CDC, 2008; Fadeel et al., 2011).  On the other hand, rapid latex agglutination test and 
lateral flow assays are also sensitive and specific and can be used when laboratory 
resources are limited (Abdoel & Smits, 2007; Marei et al., 2011). Complement fixation 
test can also be an option for diagnosis, but suffers from several drawbacks including: 
expensive reagents, the need for expert trained staff, and requires a lot of standardization 
and reagent preparation (Poester et al., 2010). The major drawback of using serological 
tests is the cross-reactivity between antigens (Rubach et al., 2013).  
At the molecular level, PCR is a sensitive and rapid method for detection of Brucella 
DNA, where multiplex PCR can be employed for confirmation and determination of the 
different species (Colmenero et al., 2011; Kumar et al., 2011). Several multiplex PCR 
assays were developed for diagnosis of species and biovars of Brucella (Yu & Nielsin, 
2010). First, AMOS PCR was used to differentiate between B. abortus, B. melitensis, B. 
ovis and B.suis (Yu & Neilsin, 2010), while the Bruce-ladder PCR was used to 
differentiate between all Brucella species including marine species B. ceti and B. 
pinnipedialis in addition to vaccine strains (Lopez-Goni et al., 2008). Furthermore, 
several Brucella genes including omp2, omp25, omp31, chaperone protein Dnak (dnaK), 
and erythrulose-1-phosphate dehydrogenase (ery) have shown to be polymorphic after 
performing restriction analysis preceded by PCR amplification of selected sequences 
(Cellier et al., 1992; Ficht et al., 1989). Finally, insertion sequence 711 (IS711) 
fingerprinting and MLVA typing are also common molecular techniques used for the 
detection and differentiation of Brucella species (Bounaadja et al., 2009; Le Fleche et 
al., 2006) 
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2.7. Treatment of Brucellosis 
Antibiotic therapy is the method of choice for treatment of brucellosis through mono- 
combination therapy (Yousefi-Noorai et al., 2012). Antibiotic susceptibility testing is 
difficult to perform mainly because the organism is fastidious and biohazardous (Abdel-
Maksoud et al., 2012). It requires biosafety level 2 or 3 and imposes risk on the 
laboratory personnel with many emerging cases of laboratory-acquired brucellosis 
(Abdel-Maksoud et al., 2012).  
Rifampin, which blocks RNA and protein synthesis intracellularly (Gattringer et al., 
2010), is the primary choice of drug in treatment of brucellosis and resulted in successful 
recovery in spite of having gastrointestinal side effects in certain patients (Xu et al., 
2013). The World Health Organization (WHO) recommends the use of doxycycline with 
rifampin or streptomycin for combination therapy (Turkmani et al., 2006). Abdel-
Maksoud et al. (2012) showed that patients who received streptomycin, doxycyline, and 
rifampin didn’t show relapse. However, ototoxicity and nephrotoxicity were seen with 
the prolonged streptomycin treatment (Ronland & Wright, 2004).  
On the other hand, levofloxacin, ceftazidime, amikacin, and sulfamethoxazole-
trimethoprim are bactericidal, and were used in the treatment of brucellosis (Xu et al., 
2013). Levofloxacin is a quinolone drug that inhibits the activity of DNA gyrase, 
prevents the DNA supercoiling, and inhibits bacterial replication (Aldred et al., 2014; 
Drlica et al., 2009). Ceftazidime on the other hand, is a β-lactam antibiotic that acts on 
the cell wall (Rawat & Nair, 2010). Successful treatment of brucellosis was the outcome 
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of using levofloxacin and ceftazidime in combination as a second choice after failing to 
treat with rifampin (Hashemi et al., 2012; Xu et al., 2013).  
Co-trimoxazole was also used in the treatment of Brucella, and has shown to be 
effective in children and pregnant women (Khan et al., 2001; Shehabi et al., 1990). 
Within the aminoglycosides, gentamicin and amikacin are two popular drugs of choice 
for treatment (Ranjbar et al., 2007).  
Due to many drawbacks associated with the use of antibiotics, studies have switched 
towards finding novel therapeutic strategies aimed at the treatment of brucellosis (de 
Figueiredo et al., 2015). The aim was to come up with anti-virulence compounds that 
will target specifically virulence factors without interfering with cellular functions and 
thus do not elicit any selective pressure on antibiotic resistance (de Figueiredo et al., 
2015). virB8, which is a vital component of the T4SS system and essential for the 
virulence of Brucella, has been a target for high throughput small molecule screening 
targeting its inactivation (Paschos et al., 2006, 2011).  
2.8. Brucellosis in the Middle East and in Lebanon 
In the Middle Eastern and North African region, cases of brucellosis have re-emerged 
due to illegal transport of animals through open borders between countries and 
breakdowns in veterinary health systems (Gwida et al., 2010). Brucellosis was detected 
in almost all domestic animals in the Middle East especially camels and goats (Al-
Shamahy, 1999).  In cattle, sheep and goats, infection was mainly common in Jordan 
and Iraq, while in camels, which have the highest rate of infection; it was mainly 
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common in Saudi Arabia, Egypt and Iran (Gwida et al., 2010). Brucellosis can be found 
also in Oman among the Bedouin community (Scrimgeour et al., 1999), in addition to 
some incidences in Libya (Ahmed et al., 2015). Control measures include vaccinations 
for people with high risk occupations and surveillance and animal control (Zhang et al., 
2014). 
In developing countries, regulatory programs aiming to eradicate brucellosis still cannot 
be fully implemented due to limited resources and economic status (Godfroid et al., 
2013). Mass vaccination particularly for sheep and goats was done in several countries, 
while test and slaughter policy in addition to vaccination of young females was 
implemented in other areas in the Middle East (Avila-Calderόn et al., 2013).  
In Lebanon, B. melitensis constitutes the main cause of brucellosis in humans (Dajani et 
al., 1989) being primarily linked to the consumption of unpasteurized milk or dairy 
products in endemic areas (Young, 1991).   
Araj and Azzam (1996) studied the sero-prevalence of Brucella˗specific antibodies in 
individuals with high-risk occupations in different areas in Lebanon (Tyre, Sidon, Shouf, 
Aley, Beirut, Biquaa, Kisrwan, Tripoli, Zgharta and Accar), and revealed that 
individuals with these occupations showed high sero-prevalence or antibody titers, 
which highlighted the need to take further protective measures to better control the 
disease and prevent its spread. 
2.9. Genome Organization and Whole-Genome Sequencing 
20 
 
 
Over the past years, whole-genome sequencing (WGS) has been crossing the threshold 
between research and clinical diagnostics due to many improvements and advancements 
including low cost and rapid turnaround time of results (Koser et al., 2012a; Loman & 
Pallen, 2008). Applications of WGS include accurate determination of phylogenetic 
relations between bacteria and this is particularly important to trace the evolutionary 
history of pathogens. This evolution is attributed to horizontal gene transfer and 
recombination events that introduce changes in bacterial genomes over time. In addition, 
many bacteria are very conserved in their genome diversity and this is where WGS 
becomes valuable (Achtman, 2008; Pearson et al., 2009). Another utilization is 
epidemiological typing that includes outbreak studies and identification of cross 
contamination between different laboratories (Schurch & Siezen, 2010). For rapidly 
evolving organisms, WGS again proves useful in terms of transmission detection across 
facilities and between patients. This is critical for outbreak and infection control (Koser 
et al., 2012b; McAdam et al., 2012). When it comes to antimicrobial susceptibility 
testing, WGS is mostly useful when genotypic and phenotypic information can be 
correlated together and this might be challenging sometimes. Phenotypic tests will still 
be needed, but WGS can complement these results obtained by detecting mutations in 
resistance-related genes for example (Koser et al., 2012a & 2012b). Also, WGS is 
suitable for detection and identification of bacteria when routine laboratory methods 
suffer several drawbacks such as lack of success in pathogen identification, and 
fastidious growth requirements needed for bacterial growth, difficult bacterial culture 
and anaerobic organisms (Kuroda et al., 2012). WGS and genome studies therefore 
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provide a potential of adding a whole new dynamic and improve work done on 
pathogenic bacterial populations in addition to ultimately replacing routine phenotypic 
and laboratory methods (Loman & Pallen, 2015).  
Sequencing of multiple Brucella species revealed that the average size of its genome is 
3.3 megabases (Mb) and is composed of two chromosomes (Halling et al., 2005). 
Brucella has been classified as being a monospecific genus, mainly after performing 
DNA-DNA pairing studies and finding greater than 95% homologies between different 
species (Mantur et al., 2007). Moreover, comparing genomes of Brucella with closely 
related genera revealed that it was once a free living organism that underwent several 
evolutionary events including the loss and acquisition of genes to subsequently become 
an animal parasite (Moreno et al., 2002). Similarities are found in the sizes, nucleotide 
composition and synteny of genes in Brucella. This shows conservation between the 
different species (Paulsen et al., 2002) particularly in the distribution of housekeeping 
genes between chromosomes, and in the similarity in the number of coding regions and 
guanosine-cytosine content (GC) (Ficht, 2011). Moreover, natural plasmids were not 
detected in Brucella (Mantur et al., 2007).  Neighboring genera also have the same 
property, which suggests that the original chromosome was separated into two units or 
that a megaplasmid was modified after its capture (Jumas-Bilak et al., 1998). Evolution 
of the organism was attributed to insertion elements, remnants of phages and presence of 
many transposons (Ficht, 2011).  
Tevdoradze et al. (2015) performed whole-genome sequencing on ten brucellaphages 
and results revealed a high degree of homogeneity. However, genetic diversity was 
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detected in the phage collar protein that provided additional insight into host selection 
with a Staphylothermus marinus F1-like CRISPR spacer and the intergenic sequences 
encoded by Ochrobactrum anthropi being also identified.  
Even though there is divergence when it comes to evolution, and despite presence of 
indels that have introduced certain variability in the virulence factors encoded between 
different species, these differences are not significant (Moreno et al., 2002). As a result, 
analysis of Brucella genomes will give an insight about the organism’s metabolism, cell 
wall features, and virulence factors that will help in better understanding its 
pathogenicity (DelVecchio et al., 2002a). 
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Chapter Three 
MATERIALS and METHODS 
3.1. Clinical Isolates 
Thirty-three Brucella isolates were kindly provided by Azm Center for Research and 
Biotechnology. Isolates were designated as Bru003-Bru011 and Bru013-Bru036 and 
were all recovered from blood except Bru016 which was recovered from articular fluid 
and Bru027 which was recovered from ascitic fluid. For whole-genome sequencing, 
sixteen isolates were chosen including: Bru003, Bru004, Bru008, Bru010, Bru013, 
Bru014, Bru015, Bru018, Bru025, Bru026, Bru027, Bru029, Bru030, Bru034, Bru035, 
and Bru036.  
3.2. DNA Extraction  
DNA was extracted using the Nucleospin Tissue kit (Macherey-Nagel, Germany) 
following the manufacturer’s instructions. 
3.3. 16S rRNA Sequencing  
3.3.1. Pre-sequencing PCR 
The 16S rRNA gene was sequenced in all the isolates (Becker et al., 2004). Initial PCR 
was done in 20 ul volume reaction using final concentrations of 2 mM dNTPs (Thermo 
Fisher Scientific), 10x Taq Buffer (Applied Biosystems), 25 mM MgCl2 (Applied 
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Biosystems), 20 uM of primers SSU-bact-27F (5’- AGAGTTTGATCMTGGCTCAG -       
3’) and SSU-bact-519R (5’- GWATTACCGCGGCKGCTG- 3’), 5 U/ul of Hotstart 
Amplitaq Gold Taq Polymerase (Applied Biosystems), and 50 ng/ul of DNA. Cycling 
conditions were as follows: initial denaturation step at 95 ºC for 12 min, 30 cycles of 
denaturation at 94 ºC for 30 s, annealing at 53 ºC for 30 s, and extension at 72 ºC for 
1min, followed by a final extension step of 72 ºC for 10 min. PCR products were 
separated for 30min at 80 V on 1% agarose gel in 1x Tris-Acetic Acid EDTA (TAE) 
buffer including 0.5 ug/mL of ethidium bromide (EtBr).   
3.3.2. PCR Cleanup 
Remaining PCR product was mixed with 0.5 ul of Exonuclease I (Thermoscientific, 
USA) and 1 ul of FastAP Thermosensitive Alkaline Phosphatase (Thermoscientific, 
USA). Cycling conditions were 37 ºC for 30 min followed by 80 ºC for 15 min. 
3.3.3. Sequencing PCR 
Sequencing PCR was performed in a 10 ul final volume using BigDye Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems, USA). A total of 7 ul of 5X diluted BigDye 
v3.1 (Applied Biosystems) and 1.2 uM primer concentration was added to 3 ul of 
purified DNA. Cycling conditions were as follows: initial denaturation step at 96 ºC for 
1 min, followed by 26 cycles of denaturation at 96 ºC for 10 s, annealing at 50 ºC for 5 s, 
and extension at 60 ºC for 4 min. 
3.3.4.Purification 
Purification was carried out using BigDye X-terminator Purification Kit (Applied 
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Biosystems, USA). Sequencing PCR product (10 ul) was pipetted into a well of a 
sequencing reaction plate. 45 ul of SAM solution (Applied Biosystems) and 10 ul X-
Terminator (Applied Biosystems) were pre-mixed and added to the PCR products. 
Sequencing reaction plate was sealed with adhesive film and vortexed for 30 min at high 
speed (1800 rpm). Finally, reaction plate was centrifuged at 1000x g for 2 min in a 
swinging-bucket centrifuge.  
3.3.5. Loading on Genetic Analyzer 
The samples were ran on the Genetic Analyzer 3500 (Applied Biosystems, USA), using 
POP7 polymer in addition to 50 cm capillary array and RapidSeq_BDX_50_POP7 run 
module. Sequences were then extracted and their quality assessed using Sequencing 
Analysis v5.4 (Applied Biosystems, USA). Forward and reverse sequences were 
assembled using CLC Main Workbench (MWB) v7.0.2 (CLCBio, Denmark). Sequences 
were blasted against NCBI 16S ribosomal RNA database to determine the closest match. 
3.4. Bruce-Ladder Multiplex PCR 
Bruce-ladder multiplex PCR for species determination of Brucella isolates was 
performed following Garcia-Yoldi et al., (2006). In a final reaction volume of 25 ul, the 
following were added: 1x PCR Buffer (Thermoscientific, USA), 400 uM dNTPs 
(Thermo Fisher Scientific), 3 mM MgCl2 (Thermoscientific, USA), 6.25 pmol of each 
primer (Table 1), 1.5 U of Taq DNA polymerase (Thermoscientific, USA) and 1 ul 
DNA. Cycling conditions were as follows: initial denaturation step at 95 ºC for 7 min, 
25 cycles of template denaturation at 95 ºC for 35 s, primer annealing at 64 ºC for 45 s, 
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and primer extension at 72 ºC for 3 min, and finally extension at 72 ºC for 6 min. 
Samples were then electrophoresed at 120 V for 1 h on 1.5% agarose prepared in 1% 
TBE Buffer (89 mM Tris/HCL, 89 mM boric acid, 2.0 mM EDTA pH= 8.0) and stained 
with 0.5 ug/ul EtBr. 500 bp and 100 bp ladders were used as size markers. Bands were 
visualized under UV light. 
Table 1. Primer sequences of forward and reverse primers used for Bruce-ladder PCR 
(Lopez-Goni et al., 2008) 
Primer 5’-3’ Sequence Target Amplicon Size 
BMEI0998f ATCCTATTGCCCCGATAAGG 1682 
BMEI0997r GCTTCGCATTTTCACTGTAGC 
BMEI0535f GCGCATTCTTCGGTTATGAA 450 (1320
*
) 
BMEI0536r CGCAGGCGAAAACAGCTATAA 
BMEII0843f TTTACACAGGCAATCCAGCA 1071 
BMEII0844r GCGTCCAGTTGTTGTTGATG 
BMEI1436f ACGCAGACGACCTTCGGTAT 794 
BMEI1435r TTTATCCATCGCCCTGTCAC 
BMEII0428f GCCGCTATTATGTGGACTGG 587 
BMEII0428r AATGACTTCACGGTCGTTCG 
BR0953f GGAACACTACGCCACCTTGT 272 
BR0953r GATGGAGCAAACGCTGAAG 
BMEI0752f CAGGCAAACCCTCAGAAGC 218 
BMEI0752r GATGTGGTAACGCACACCAA 
BMEII0987f CGCAGACAGTGACCATCAAA  152 
BMEII0987r GTATTCAGCCCCCGTTACCT 
*In marine isolates, the amplicon size is 1320 bp due to an insertion in bp26 gene (Lopez-Goni et al., 2008). 
3.5. Polymerase Chain Reaction -Restriction Fragment Length 
Polymorphism (PCR-RFLP) of omp31 gene 
PCR was performed in a 25 ul volume reaction containing 1x Taq Buffer 
(Thermoscientific, USA), 0.2 mM dNTPs (Thermo Fisher Scientific), 1 uM of primers 
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31sd (5’- TGACAGACTTTTTCGCCGAA- 3’) and 31ter (5’- 
CATTCAGGACAATTCCCGCC- 3’), 1 mM MgCl2 (Thermoscientific, USA), 1 U Taq 
Polymerase (Thermoscientific, USA), and 100 ng genomic DNA (Garcia-Yoldi et al., 
2005; Vizcaino et al., 1997). Cycling conditions were as follows: initial denaturation at 
94 ºC for 5 min, followed by 30 cycles of 58 ºC for 30 s, 70 ºC for 30 s, and 94 ºC for 30 
s, then 58 ºC for 30 s, and finally extension at 70 ºC for 10 min. Each PCR product (5 ul) 
was cleaved in a 20 ul volume reaction with 5 U of restriction enzyme HaeIII (BsuRI) 
(Thermo Fisher Scientific) for 3 h at 37 ºC according to the manufacturer’s instructions. 
Both PCR products and restriction fragments were run on 1.5% agarose gel in 1x TBE 
and stained with 0.5 ug/ul EtBr at 120 V for 1 h. As size markers, 500 bp and 100 bp 
ladders were used. 
3.6. PCR-RFLP of omp2a gene 
PCR was performed on sequenced isolates in a 50 ul final reaction volume containing 1x 
PCR buffer (Thermoscientific, USA), 2 mM MgCl2 (Thermoscientific, USA), 0.15 mM 
dNTPs (Thermo Fisher Scientific), 2.5 U Taq polymerase (Thermoscientific, USA), 20 
pmol of primers 2aA (5’- GGCTATTCAAAATTCTGGCG- 3’) and 2aB (5’- 
ATCGATTCTCACGCTTTCGT- 3’) and 0.5 ug of template DNA (Cloeckaert et al., 
1995; Mirnejad et al., 2013). Cycling conditions were as follows: pre-denaturation step 
for 5 min at 94 ºC, followed by 35 cycles of denaturation at 94 ºC for 60 s, annealing at 
50 ºC for 120 s, and extension at 72 ºC for 180 s, and finally an extension step at 72 ºC 
for 7 min. PCR products were ran on 1% agarose gel in 1x TBE and stained with 0.5 
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ug/ul EtBr at 80 V for 30 min. PCR product (7 ul) was cleaved in a 15 ul reaction 
volume containing 0.3 ul (10-20 U) of HinfI restriction enzyme (Thermo Fisher 
Scientific), 6 ul nuclease free water and 1.7 ul enzyme buffer at 37 ºC for 2 h.  
Restriction fragments were run on 2% agarose gel in 1x TBE and stained with 0.5 ug/ul 
EtBr at 120 V for 1 h. Size markers (500 bp and 100 bp ladders) were used.  
3.7. Genome Sequencing 
One ng of genomic DNA (gDNA) from each isolate was used as input for library 
preparation using the Nextera XT library prep kit (Illumina, Inc., San Diego, CA). The 
subsequent clean up steps were performed using the AMPure XP PCR purification beads 
(Agencourt, Brea, CA) following manufacturer’s instructions. The resulting library was 
quantified by quantitative PCR in triplicate at 1:1000 and 1:2000 and using the Kapa 
library quantification kit (Kapa Biosystems, Woburn, MA) and as recommended by the 
manufacturer’s protocol. The samples were pooled together and then sequenced on an 
Illumina Miseq for paired-end 250-bp reads. 
3.8. Analysis of sequencing results 
3.8.1. Assembly of the genome 
After sequencing, de novo genome assembly was done using A5-miseq assembly 
pipeline keeping default parameters (Tritt et al., 2012). Data cleaning, error correction, 
contig assembly, scaffolding and quality control processes are all automated by this 
pipeline.  
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3.8.2. Annotation of the genome using RAST 
The resulting de novo assemblies were annotated using the RAST server 
(http://rast.nmpdr.org) (Aziz et al., 2012). This service determines subsystems 
represented in the genome, protein-coding, tRNA, and rRNA genes and assigns their 
functions (Larsen et al., 2012).  
3.8.3. Species Identification 
KmerFinder tool was used to predict the species of bacteria based on the number of co-
occurring k-mers in DNA ( www.genomicepidemiology.org), which are substrings of k 
nucleotides found in the subsequent DNA sequence (Hasman et al., 2013). Genomes 
were also blasted on NCBI and RAST was used to determine closest neighbors 
(http://rast.nmpdr.org) (Aziz et al., 2012). 
3.8.4. Detection of virulence and resistance determinants 
To study virulence and resistance, the SEED viewer service from the RAST server was 
used in addition to the VFDB tool on the Online Analysis Tools website (http://molbiol-
tools.ca/Genomics.htm) (Chen et al., 2012). The Brucella Bioinformatics Portal (BBP) 
which is a web-based portal for Brucella genome annotation was also used (Xiang et al., 
2006).  
3.8.5. Identification and localization of T4SS components and flagellar genes 
T4SS and flagellar gene components were annotated using RAST and also, core 
components of the T3SS and T4SS were searched using the T346Hunter application 
(Martinez-Garcia et al., 2015).  
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3.8.6. Detection of phages and mobile elements  
Phage Search Tool (PHAST) (http://phast.wishartlab.com/index.html) (Zhou et al., 
2011) was used to detect phages, sites of integration and closest identity match.  
3.8.7. Detection of CRISPRs 
CRISPR loci were identified using CRISPRfinder program (http://crispr.u-
psud.fr/Server/) (Grissa et al., 2007). 
3.8.8. Detection of insertion sequences 
Insertion sequences were detected using Biotoul IS-Finder (http://www-is.biotoul.fr/) 
(Siguier et al., 2006).  
3.8.9. Detection of Genomic Islands 
IslandViewer (http://pathogenomics.sfu.ca/islandviewer) (Dhillon et al., 2015) was used 
for the identification of pathogenicity islands. It predicts genomic islands by using three 
different tools: SIGI-HMM, IslandPath-DIMOB, and IslandPick. 
3.8.10. Construction of circular genomes 
Based on sequence analysis results, CGview Server V 1.0 (Grant & Stothard, 2008) was 
used to visualize the sequence feature information, and circular genome representation 
of sequenced isolates was obtained through comparison with B. melitensis 16M 
reference genome (accession #: NC_003317 and NC_003318)  (DelVecchio et al., 
2002b). DNAPlotter (Carver et al, 2009) was used for circular genome maps 
visualization.  
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3.8.11. Construction of phylogenetic tree 
To determine the phylogenetic relationship of our strains, 37 concatenated marker genes 
were used to construct a maximum-likelihood tree using seven B. melitensis reference 
genomes (16M, ATCC 23457, Ether, NI, M5-90, M28, and strain 63/9), plus other 
Brucella species (B. abortus 2308 and strain 9-941, B. canis, B. ceti, B. pinnipedialis, B. 
microti, B. suis, B. ovis and B. vulpis). Ochrobactrum anthropi was used as an outgroup 
to root the tree. First, the genomes were processed with PhyloSift (Darling et al, 2014), 
then FastTree was used to construct the tree (Price et al, 2010), and Dendroscope (Huson 
& Scornavacca, 2012) was used to edit and visualize the tree. While constructing trees 
based on individual genes in Phylosift will give congruent results, their concatenation 
helps improve rare organism detection among microbial organisms and give a more 
accurate estimate of phylogenetic history (Darling et al., 2014).  
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Chapter Four 
RESULTS 
4.1. 16S rRNA Sequencing  
16S rRNA gene was sequenced in all the isolates. 16S rRNA sequencing confirmed that 
all the isolates belonged to Brucella genus. Top three blast results for each isolate are 
represented in Table 2. 
Table 2. Top three NCBI Blast results using 16S rRNA database for all thirty-three 
Brucella isolates. 
 
 
4.2. Bruce-Ladder Multiplex PCR 
Isolate # Blast result 
3, 4, 6, 8, 9, 10, 
11, 13, 14, 15, 16, 
17, 18, 19, 20, 21, 
23, 24, 25, 26, 27, 
29, 30, 31, 32, 33, 
34, 35, 36 
Brucella ceti 16S ribosomal RNA, complete sequence 
Brucella suis 1330 16S ribosomal RNA gene, complete sequence 
Brucella ovis strain ATCC 25840 16S ribosomal RNA gene, 
complete sequence 
5, 7, 22, 28 Brucella ceti 16S ribosomal RNA, complete sequence 
Brucella suis 1330 16S ribosomal RNA gene, complete sequence 
Brucella melitensis biovar abortus 2308 strain 2308 16S ribosomal 
RNA, complete sequence 
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In all Brucella isolates a transcriptional regulator belonging to CRP family (152 bp), 
immunodominant antigen bp26 (450 bp), erythritol catabolism gene eryC (587 bp) and 
polysaccharide deacetylase (794 bp) were amplified (Figure 2).  
 
Figure 2. Agarose gel electrophoresis of PCR amplified products generated from DNA 
samples after Bruce-ladder multiplex PCR. Lanes M1 and M2 are 500 bp and 100 bp 
ladders respectively, lanes 1-12 show PCR products obtained with Brucella isolates, and 
lane 13 is negative control. 
 
4.3. PCR-RFLP of omp31 gene 
omp31 gene (900 bp) was found in all isolates (Figure 3), and the P1 pattern was 
obtained as a result of enzymatic digestion with HaeIII enzyme. P1 pattern consisted of 
three bands with the sizes being around 210 bp, 280 bp, and 320 bp (Figure 4). 
 
34 
 
 
 
Figure 3. Agarose gel electrophoresis of PCR amplified omp31 genes generated from 
DNA samples. Lane M1 is the 500 bp ladder, lanes 1, 2, 4, 5 show PCR products 
obtained with Brucella isolates, and lanes 3, 6 are negative controls. 
 
 
Figure 4. Restriction patterns of PCR amplified omp31 genes digested by HaeIII 
enzyme. Lane M1 and M2 are the 500 bp and 100 bp ladders respectively, lanes 1, 2, 4, 
5 show restriction products obtained with Brucella isolates, and lanes 3, 6 are negative 
controls. 
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4.4. PCR-RFLP of omp2a gene 
In all sixteen sequenced isolates, the omp2a gene was detected (1100 bp) (Figure 5), and 
P2 pattern was obtained after enzymatic digestion with Hinf1 enzyme. P2 pattern 
consisted of three bands of sizes around 210 bp, 270 bp and 550 bp (Figure 6).  
 
Figure 5. Agarose gel electrophoresis of PCR amplified omp2a genes generated from 
DNA samples. Lanes M1 and M2 are the 500 bp and 100 bp ladders respectively. Lanes 
1, 2, 3, 4, 5, 6, 7, 8, 9 show PCR products obtained with Brucella isolates, and lane 10 is 
a negative control. 
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Figure 6. Restriction patterns of PCR amplified omp2a genes digested by Hinf1 
enzyme. Lanes M1 and M2 are the 500 bp and 100 bp ladders respectively. Lanes 1, 2, 
3, 4, 5, 6, 7, 8, 9 show restriction products obtained with Brucella isolates, and lane 10 is 
a negative control. 
 
4.5. Whole-genome Sequencing 
Bru003, Bru004, Bru008, Bru010, Bru013, Bru014, Bru015, Bru018, Bru025, Bru026, 
Bru027, Bru029, Bru030, Bru034, Bru035, Bru036 were chosen for whole-genome 
sequencing, all of which were recovered from blood except Bru027 recovered from 
ascitic fluid. The libraries were prepared using Nextera XT library prep kit (Illumina, 
Inc., San Diego, CA), and sequenced on an Illumina Miseq for paired-end 250-bp reads. 
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The A5-miseq assembly pipeline was used for de novo genome assembly (Tritt et al., 
2012). 
4.6. Genome Statistics 
The average detected genome size was 3,297,621 bp (ranging from 3,290,179 bp to 
3,322,963 bp). Number of contigs ranged from 34 to 80. The G + C content was 57.2 ± 
0.1%, and the number of detected subsystems was 434 ± 4. The average number of 
coding sequences was 3327 (ranging from 3314 to 3339), with 56 RNAs being detected 
in all sixteen isolates (Table 3).   
Table 3. Comparative genomic statistics of sixteen sequenced Brucella genomes. 
Sample Bru 004 Bru 008 Bru 010 Bru 013 Bru 018 Bru 026 Bru 029 Bru 034 
Size (bp) 3298639 3298358 3296555 3305257 3300556 3296220 3294296 3296602 
Number of contigs 58 59 55 58 70 53 41 53 
G + C Content (%) 57.2 57.2 57.2 57.2 57.3 57.2 57.2 57.2 
Number of subsystems 434 434 434 433 435 434 434 434 
Number of coding sequences 3337 3329 3334 3335 3338 3325 3339 3323 
Number of RNAs 56 56 56 56 56 56 56 56 
Sample Bru 003 Bru 014 Bru015 Bru 025 Bru 027 Bru 036 Bru 030 Bru 035 
Size (bp) 3290766 3291305 3322963 3290178 3290853 3295865 3297707 3295809 
Number of contigs 37 34 80 34 36 45 57 46 
G + C Content (%) 57.2 57.2 57.1 57.2 57.2 57.2 57.2 57.2 
Number of subsystems 436 436 438 436 436 436 434 434 
Number of coding sequences 3327 3314 3329 3318 3317 3321 3320 3320 
Number of RNAs 56 56 56 56 56 56 56 56 
4.7. Determination of species of Brucella   
All sixteen sequenced genomes were confirmed to be B. melitensis using KmerFinder 
tool along with NCBI Blast and RAST.  
4.8. Genome annotation using RAST 
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Figure 7 represents the distribution of genes assigned to subsystems using RAST. 
Among SEED subsystem categories, genes coding for amino acids and derivatives (416 
ORFs), carbohydrates (356 ORFs), cofactors, vitamins, prosthetic groups, and pigments 
(265 ORFs),  and protein metabolism (248 ORFs) were abundant. 
 
Figure 7. Distribution of subsystem categories of our genomes based on SEED 
databases.  
The main virulence factors were classified into genes involved in secretion systems 
(T4SS and flagellar genes), LPS related genes involved in biosynthesis of O-antigen 
(genes encoding phosphomannomutase, mannose 6-phosphate isomerase, and mannose 
guanylyltransferase), ureases (ureA, ureB, ureC, ureD, ureE, ureF, and ureG) , BvrR/S 
two component system (encoded by chvI and chvG), regulation of gene expression (hfq), 
cyclic β-1,2-glucan cgs (ndvb), and stringent response (spoT/rsh). 
4.9. Resistance profiles 
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The antimicrobial susceptibility testing was performed using the disk diffusion method 
for: ofloxacin, minocycline, rifampicin, tetracycline, gentamicin, ciprofloxacin, and 
sulfamethoxazole/trimethoprim (Hamzeh, personal communication). All isolates were 
susceptible to tetracyclines (minocycline and tetracycline), aminoglycosides 
(gentamicin), and rifamycins (rifampicin). Resistance to ofloxacin (fluoroquinolones) 
was detected in Bru007 and Bru028, whereas Bru029 was resistant to ciprofloxacin 
(Hamzeh, personal communication). The NorMI efflux pump which confers resistance 
to fluoroquinolones, in addition to gyrA, gyrB, parC, and parE, were all detected in the 
sequenced genomes.  The former genes encode: DNA gyrase subunit A, DNA gyrase 
subunit B, DNA topoisomerase IV subunit A, and DNA topoisomerase IV subunit B 
which also play a role in fluoroquinolone resistance. Resistance to trimethoprim and 
sulfonamide was detected in 14 isolates (Bru003, Bru014, Bru015, Bru017, Bru019, 
Bru020, Bru021, Bru022, Bru023, Bru024, Bru028, Bru030, Bru031 and Bru032) 
(Hamzeh, personal communication), which carried the RND efflux pumps (confer 
resistance to trimethoprim). 
4.10. Detection of phages and mobile elements 
At least two prophages were detected per sequenced genome ranging in size between 6.1 
and 60.4 kb. An intact 13.7kb phage (Paraco_vB_Pmas) and a 17.4kb incomplete phage 
(Acanth_moumouvirus) were present in all except for Bru013 and Bru018, which were 
negative for the Paraco_vB_Pmas phage and the Acanth_moumouvirus phage, 
respectively. Staphy_SPbeta_like phage was detected in isolates Bru003, Bru025 and 
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Bru036. However, phages Plankt_PaV_LD, Lactoc_jj50, Lactob_prophage_Lj965, 
Salmon_ST64B, and Pandor_inopinatum were only detected in Bru010, Bru015, 
Bru035, Bru013 and Bru018 respectively (Table 4).  
Table 4. Phage associated regions in Brucella genomes. 
Isolate Related phages Size (kb) Status Sco
re 
CD
S 
GC 
content 
(%) 
Bru 003 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.17% 
Staphy_SPbeta_like 38.8 kb Intact 150 27 53.49% 
Bru 004 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.15% 
Paraco_vB_Pmas 13.7 kb Intact 140 19 61.19% 
Bru 008 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Bru 010 Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Plankt_PaV_LD 6.1 kb Incomplete 40 7 56.41% 
Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Bru 013 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.05% 
Salmon_ST64B 24.1 kb Intact 150 35 58.41% 
Bru 014 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.05% 
Paraco_vB_Pmas 17 kb Intact 150 22 60.39% 
Bru 015 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 19 61.17% 
Lactoc_jj50 60.4 kb Intact 150 62 47.21% 
Bru 025 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Staphy_SPbeta_like 33.1 kb Intact 140 30 53.20% 
Bru 026 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.15% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Bru 027 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 19 61.19% 
Bru 029 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.15% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19%  
Bru 030 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.15% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Bru 034 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.14% 
Paraco_vB_Pmas 24.1 kb Intact 150 32 58.44% 
Bru 035 Acanth_moumouvirus 22.6 kb Incomplete 20 14 58.15% 
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Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Lactob_prophage_Lj9
65 
9.7 kb Incomplete 40 8 51.22% 
Bru 036 Acanth_moumouvirus 17.4 kb Incomplete 20 14 58.06% 
Paraco_vB_Pmas 13.7 kb Intact 140 18 61.19% 
Staphy_SPbeta_like 20.4 kb Intact  120 23 52.47% 
Bru 018 Pandor_inopinatum 9 kb Incomplete 30 12 54.30% 
Paraco_vB_Pmas 13.6 kb Intact 140 19 61.11% 
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Figures 8 and 9 are graphical presentations for Acanth_moumouvirus and 
Paraco_vB_Pmas phages detected in Bru003, where the figures show the number of 
coding DNA sequences, GC content, location, and predicted prophage status in addition 
to a legend at the bottom representing the types of coding sequences identified. A 
circular graphical representation showing the location of the three detected phages in 
Bru003 is shown in Figure 10. 
 
Figure 8. Linear graphical representation of Acanth_moumouvirus phage in Bru003. 
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Figure 9. Linear graphical representation of Paraco_vB_Pmas phage in Bru003. 
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Figure 10. Circular graphical representation showing the location of the three detected 
phages in Bru003. 
4.11. Detection of genomic islands 
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Islandviewer 3 was used to detect genomic islands aligning the genomes with reference 
strain B. melitensis 16M. LPS related genes, exonucleases, outer membrane proteins 
were found in several islands detected in the sequenced isolates (Table 5). Additionally, 
genes from virB operon (virB2, virB3, virB4, virB5, virB6, and virB8) involved in type 
IV secretion system were detected in Bru015.  
Table 5. Genes found on genomic islands detected by Islandviewer3. 
 wbkE per gmd wboA wboB wbkC wbkA Outer 
membrane 
protein 
Exonuclease 
Bru003 - + + + + + + - - 
Bru004 - + + + + + + - - 
Bru008 + + + + + + + + - 
Bru010 - + + + + + + - - 
Bru013 - + + + + + + - + 
Bru014 - + + + + + + + + 
Bru015 - + + + + + + + + 
Bru018 - + + + + + + - - 
Bru025 + + + + + + + - - 
Bru026 - + + + + + + + - 
Bru027 - + + + + + + - - 
Bru029 - + + + + + + + + 
Bru030 - + + + + + + - - 
Bru034 - + + + + + + - - 
Bru035 - + + + + + + - + 
Bru036 - + + + + + + - - 
 
4.12. CRISPR detection 
All sixteen sequenced isolates were shown to have one possible CRISPR with a size of 
82 bp containing one spacer.   
4.13. Identification and localization of T4SS and flagellar components 
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For T4SS components, virB 1-11 were detected in all the sixteen sequenced genomes 
using RAST and T346 Hunter. The components of T4SS were within one gene cluster. 
Table 6 shows the eleven core components of T4SS and their corresponding annotations. 
A linear graphical representation of T4SS core components of Bru014 was constructed 
using T346Hunter, where predicted ORFs of the core components are shown in red 
(Figure 11). Three gene clusters linked to flagellar components were also detected using 
T346Hunter. The core components comprising the three gene clusters and their 
corresponding annotations and functions are shown in Table 7. A linear graphical 
presentation of one of the three T3SS clusters is displayed in Figure 12, where predicted 
ORFs of core components are shown in red.  
Table 6. Core components of T4SS. 
Gene Corresponding protein 
virB1 Peptidoglycan hydrolase involved in T-DNA transfer 
virB2 Major pilus subunit of type IV secretion complex 
virB3 Inner membrane protein forms channel for type IV secretion of T-DNA 
complex 
virB4 ATPase required for both assembly of type IV secretion complex and 
secretion of T-DNA complex 
virB5 Minor pilin of type IV secretion complex 
virB6 Inner membrane protein of type IV secretion of T-DNA complex 
virB7 Lipoprotein of type IV secretion complex that spans outer membrane and 
periplasm 
virB8 Inner membrane protein forms channel for type IV secretion of T-DNA 
complex 
virB9 Outer membrane and periplasm component of type IV secretion of T-DNA 
complex, has secretin-like domain 
virB10 Inner membrane protein of type IV secretion of T-DNA complex, TonB-
like 
virB11 ATPase required for both assembly of type IV secretion complex and 
secretion of T-DNA complex 
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Table 7. Flagellar genes detected using T346Hunter. 
Gene Corresponding protein 
flip Flagellar biosynthesis protein FliP 
flgI Flagellar P-ring protein FlgI 
flgA Flagellar basal-body P-ring formation protein FlgA 
flgG Flagellar basal-body rod protein FlgG 
fliE Flagellar hook-basal body complex protein FliE 
flgC Flagellar basal-body rod protein FlgC 
flgB Flagellar basal-body rod protein FlgB 
fliI Flagellum-specific ATP synthase FliI 
flgF Flagellar basal-body rod protein FlgF 
motA Flagellar motor rotation protein MotA 
fliM Flagellar motor switch protein FliM 
fliN Flagellar motor switch protein FliN 
fliG Flagellar motor switch protein FliG 
flhB Flagellar biosynthesis protein FlhB 
fliR Flagellar biosynthesis protein FliR 
flhA Flagellar biosynthesis protein FlhA 
fliQ Flagellar biosynthesis protein FliQ 
flgD Flagellar basal-body rod modification protein FlgD 
flgL Flagellar hook-associated protein FlgL 
flgK Flagellar hook-associated protein FlgK 
flgE Flagellar hook protein FlgE 
fliK Flagellar hook-length control protein FliK 
motB Flagellar motor rotation protein MotB 
fliF Flagellar M-ring protein FliF 
fliC Flagellin 
 
 
 
Figure 11. Graphical linear presentation of ORFs constituting the core components of 
T4SS in Bru014. 
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Figure 12. Graphical linear presentation of eight ORFs constituting the core components 
of T3SS cluster one in Bru014. 
4.14. Detection of insertion sequences 
ISL3, IS3, IS481, IS711 and IS5 were detected using IS Finder in all sixteen sequenced 
genomes. IS66 was also detected in Bru018, Bru029 and Bru035 and IS110 in Bru004, 
Bru008, Bru010, Bru014, Bru029, Bru030 and Bru034. Figure 13 is a representative of 
the pie chart for Bru004 showing the insertion sequences detected and their 
corresponding percentages.  
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Figure 13. Representative figure of insertion sequences detected in sample Bru004 by IS 
Finder Tool. 
4.15. Phylogenetic analysis  
Phylogenetic analysis revealed the clustering of the sequenced isolates in five clades 
separately from other B. melitensis reference strains. Bru003, Bru015 and Bru034 were 
clustered in the same clade, and distant from the rest of the sequenced B. melitensis 
isolates used in this study, which in turn clustered into 4 clades (Figure 14). 
 
 
Figure 14. Maximum-likelihood concatenated marker tree of all Brucella strains used in 
this study. After downloading the genomes from the NCBI database, the filenames and 
sequences were reformatted for easier visualization. Phylosift was then used to screen 
the assemblies for core marker genes in search and align mode using isolate and best hit 
flags. PhyloSift concatenates and aligns the hits of interest. The sequences are then 
extracted from the PhyloSift output files and added to a single file to build the tree. 
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FastTree was used to infer the maximum-likelihood tree and Dendroscope was used for 
tree visualization. 
4.16. Construction of circular genomes 
DNAPlotter was used to generate a circular map of the genomes showing the sequences, 
tRNAs, and GC plot and skew (Figure 15). CGview on the other hand, aligned regions 
of the sequenced genomes to B. melitensis str. 16M which was used as a reference 
genome (Figure 16). The circular map shows the sequences, G+C content and skew, and 
BLAST results against the reference genome. 
 
 
Figure 15. Circular map of Bru004 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 16. Circular map of Bru004 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru004 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Chapter Five 
DISCUSSION 
B. melitensis is the major cause of brucellosis in the Middle East and Lebanon and 
mostly isolated from humans (Araj, & Azzam, 1996; Avila-Calderon et al., 2013). This 
study aimed at analyzing the genomic and functional attributes of sixteen sequenced 
Brucella genomes. In Lebanon, the virulence factors and genotypic characteristics of 
Brucella were not thoroughly identified and there was a lack of data on the 
pathogenomics of this important human pathogen. 
5.1. Typing of Brucella  
In this study, 16S rRNA sequencing, Bruce-ladder multiplex PCR and PCR-RFLP of 
omp31 and omp2a gene were performed.  16S rRNA is a rapid test used to confirm 
Brucella at the genus level, but suffers from low accuracy in differentiating isolates at 
the species level due the low variability in the locus (Gee et al., 2004; Vizcaino et al, 
2000). Using 16S rRNA sequencing all isolates were confirmed to belong to the genus 
Brucella. Bruce-ladder multiplex PCR was then performed to further type the organisms 
at the species level. This PCR assay can further differentiate between species including 
vaccine strains and ones infecting marine mammals (Lopez-Goni et al., 2008). Four 
genes were detected in all the isolates including a transcriptional regulator belonging to 
the CRP family, erythritol catabolism eryC gene, polysaccharide deacetylase gene and 
immunodominant gene bp26 suggesting that the isolates could be either B. abortus, B. 
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melitensis, B. ovis or B. suis. However, based on the absence of specific genes (Lopez-
Goni et al., 2008), we were able to eliminate the following species: B. canis, B. ceti, B. 
pinnipedialis or B. neotomae. The polysaccharide deacetylase gene is absent from B. 
canis, the bp26 gene is absent from B. ceti and B. pinnipedialis and the transcriptional 
regulator belonging to the CRP family is missing in B. neotomae, all of which were 
detected in the isolates undertaken in this study. Accordingly, while the Bruce-ladder 
approach ruled out B. canis, B. ceti, B. pinnipedialis and B. neotomae, it was not 
conclusive.  
Because of their polymorphism, Brucella outer membrane proteins have been used for 
species and biovars differentiation (Pishva et al., 2015; Vizcaino et al., 1997). 
Previously, PCR-RFLP analysis of omp31 gene showed that it was deleted in B. abortus. 
This was confirmed by genome sequencing where a 25-kb deletion was found linked to 
the absence of omp31 and other adjacent genes involved in synthesis of polysaccharide 
compared to other Brucella species (Vizcaino et al., 2001a). This method also 
differentiated B. suis biovar 2 from other Brucella species (Garcia-Yoldi et al., 2005; 
Vizcaino et al., 1997). The interest in omp31 as a candidate for typing comes not only 
from its polymorphic characteristic but also from the fact that it is an immunodominant 
antigen and provides protective immunity against Brucella infection. It also possesses 
heme-binding properties and it is induced under conditions of limited iron availability 
(Delpino et al., 2006; Vizcaino et al., 2001b).  Conducting the omp31 PCR assay on all 
the isolates revealed that all carried the gene, thus confirming that they don’t belong to 
B. abortus. In addition to that, the obtained restriction digestion pattern, P1, using HaeIII 
54 
 
 
enzyme ruled out B. suis biovar 2. omp2a is another candidate and target for PCR-RFLP 
analysis and differentiation of species and biovars of Brucella (Cloeckaert et al., 1995; 
Mirnejad et al., 2013). It is considered as an immunogenic antigen in addition to being a 
virulence factor (Cloeckaert et al., 1996). P2 pattern was obtained upon restriction 
digestion of omp2a using HinfI enzyme; a pattern usually associated with B. melitensis 
or B. ovis. However, through whole-genome sequencing and the use of different online 
tools (KmerFinder, BLAST and RAST), all sequenced genomes were confirmed to be B. 
melitensis. 
5.2. Genome sequencing  
5.2.1. Virulence determinants 
Brucella lacks the classical virulence determinants usually detected in other pathogens 
such as cytolysins, exotoxins, fimbriae, plasmids and antigenic variation (Moreno & 
Moriyon, 2002). The most important virulence determinants that were detected in all our 
sequenced genomes can be classified into the following categories: genes involved in 
secretion systems (T4SS and flagellar genes), LPS related genes involved in 
biosynthesis of O-antigen (manA, manB, manC), ureases (ureA, ureB, ureC, ureD, ureE, 
ureF, and ureG) , BvrR/S two component system (encoded by chvI and chvG),  cyclic β-
1,2-glucan cgs (ndvb), regulation of gene expression (hfq), and stringent response 
(spoT/rsh).  
Secretion systems in Brucella, specifically the T4SS and flagellar genes are considered 
key virulence factors (He, 2012). T4SS is needed for late stages of infection and for 
55 
 
 
chronic persistence (Hong et al, 2000), through upregulating omp25 and omp31 and 
adapting to a stressful environment (Wang et al., 2009a).  The Brucella T4SS is intact 
(Celli et al., 2003), and mediates inflammatory response in addition to vesicle trafficking 
in the host cell (Ke et al., 2015). These features distinguish Brucella from other Gram-
negative bacteria, with the T4SS being used for other purposes such as transformation 
and DNA uptake similar to Helicobacter pylori and Neisseria gonorrhoeae (Wallden et 
al., 2010). Components of the Brucella T4SS are encoded by the virB operon composed 
of 11 genes (virB1-11), which was detected in all sequenced isolates in this study except 
for virB7, encoding lipoprotein of T4SS that spans the outer membrane and periplasm. 
virB7, virB9, and virB10 are part of the outer membrane complex, while the inner 
membrane complex is composed of virB3, virB4, virB6, virB8, and N-terminus of 
virB10. The energy center is composed of virB4 and virB11, while virB2 is the 
stretching needle complex and finally remnants of virB5 and virB10 constitute the 
linking stalk (Low et al., 2014, Trokter et al., 2014). virB1 and virB7 do not play an 
important role in Brucella virulence as opposed to the other proteins in the system (Ke et 
al., 2015), but virB7’s importance lies in the fact that even though the T4SS is conserved 
among all Brucella spp., the virB7 in particular is dynamic (Sankarasubramanian et al., 
2016). This variability in the presence/absence of virB7 was observed in different 
species of Brucella; absent in some strains of B. abortus, B. ovis, B. canis and B. suis 
and absent in two strains of B. melitensis: strain M28 and M5-90. This however, could 
additionally indicate that our isolates were closely related to M5-90 and M28 B. 
melitensis strains (Sankarasubramanian et al., 2016).  
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Despite being non-motile, remnants of genes required for flagellar assembly were 
detected in all our sequenced isolates distributed into three gene clusters as was 
previously reported by Fretin et al. (2005). Among those detected were: fliF gene 
encoding a monomer of the MS- ring and regulated by FtcR, which controls flagella 
expression (Leonard et al., 2007). The hook encoded by flgE and the filament by fliC 
gene, which is also in turn responsible for production of flagellin in B. melitensis and is 
regulated by flbt (Ferooz et al., 2011). The motB encodes a motor rotation protein, fliN 
encodes a motor switch protein, flhA and flhB encode the export apparatus, flgD encodes 
a hook capping protein, flgF encodes for a basal body rod protein and flgL encodes a 
hook-associated protein (Fretin et al., 2005). Chemotactic proteins however, such as 
CheA, CheB, CheW, CheR, were all absent from the sequenced genomes in this study, 
which further confirms that the flagellar system in Brucella is cryptic and only contains 
remnants of genes (Pallen & Matzke, 2006). What distinguished this flagellar apparatus 
in Brucella from other non-motile organisms is the fact that the latter don’t utilize it for 
infection, whereas in Brucella it is considered as a key virulence factor (Fretin et al., 
2005). In B. melitensis, the distinguishing feature is that those set of genes code for a 
sheathed flagellum, which is expressed transiently under certain conditions and causes 
persistent infection, unlike its use in other species (Leonard et al., 2007). This all 
illustrates that although Brucella has lost motility due to its evolution from inhabiting 
soil to one that survives intracellularly, but the system is not only important for motility 
but also for persistence and infection (Pallen & Matzke, 2006).  
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Another aspect of Brucella virulence is the BvrR/S two-component system, where chvI 
codes for a response regulator and chvG encodes for the sensor histidine kinase (Rossetti 
et al., 2011). Both were detected in all the sequenced genomes in this study, coding for 
the homologs of BvrR/BvrS TCS found in B. abortus. This system’s significance lies in 
its ability to upregulate the outer membrane proteins needed to penetrate host cells 
(Omp22 and Omp25), and genes in the virB operon (virB1, virB5, virB8, and virB9), 
thus acting as a transcriptional regulator (Lamontagne et al., 2007; Martinez-Nunez et 
al., 2010). Therefore, a successful intracellular infection in host cells and proper 
vacuolar maturation is ensured through this two component system and its subsequent 
interaction with the T4SS components mentioned earlier (Lopez- Goni et al., 2002; 
Martinez-Nunez et al., 2010).  
Moreover, ureA, ureB, ureC, ureD, ureE, ureF, and ureG were all found in the 
sequenced B. melitensis in this study, encoding for two urease operons. The ureD, ureE, 
ureF and ureG are accessory genes involved in the assembly of ureases (Paulsen et al., 
2002; Sangari el al., 2007). What distinguished B. melitensis ureases from ureases in 
other Brucella species, is the fact that they are needed for the successful establishment of 
an infection in the digestive tract instead of the oral cavity as in B. abortus (Paixao et al., 
2009), and it does so by allowing B. melitensis to withstand the harsh, acidic 
environment (Seleem et al., 2008).  
rsh gene encoding a homologue of spoT gene found in E. coli was also detected and it 
encodes a ppGpp (guanosine pentaphosphate) synthetase (Mittenhuber, 2001). The rsh is 
90% similar to that of B. suis and also very closely related (70%) to spoT in 
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Sinorhizobium meliloti. It has two important functions in Brucella: cope with nutrient 
deprivation conditions and regulate the expression of T4SS in Brucella, with isolates 
lacking rsh having no functional T4SS (Dozot et al., 2006). Hfq also regulates the 
expression of T4SS in B. melitensis and B. abortus and was detected in all the sequenced 
genomes of this study. Hfq however, has a more prominent role in the virulence of B. 
melitensis than that of B. abortus, as it regulates 11% of Brucella genes including 
superoxide dismutase either directly or indirectly and therefore has been considered as 
an important virulence factor as well (Caswell et al., 2012; Mingquan et al., 2013). Hfq 
plays a role in causing chronic or persistent infection by overcoming host stresses and by 
regulating key stress response factors (Kaufmann, 2011). 
Moreover, manA, manB (pmm), manC genes were all found in our sequenced genomes 
encoding for phosphomannomutase, mannose-6-phosphate isomerase, and mannose 
guanylyltransferase respectively, with all being involved in O- antigen biosynthesis. LPS 
interferes with the host’s anti-microbial compounds and renders the organism resistant to 
defensins and lysozymes (Lapaque et al., 2005; Tumurkhuu et al., 2006). Brucella LPS 
is distinguished from other organisms as its lipid A fatty acid chain is unusually longer, 
and more virulent than other organisms (Cardoso et al., 2006; Haag et al., 2010), 
highlighting the importance of the LPS in Brucella fitness. 
Our findings suggest that despite the absence of classical virulence determinants, B. 
melitensis has an abundant repertoire of virulence factors that contribute to its fitness 
and pathogenicity. 
59 
 
 
5.2.2. Resistance patterns 
Fluoroquinolone resistance was detected in Bru007, Bru028 and Bru029, while co-
trimoxazole resistance in Bru003, Bru014, Bru015, Bru017, Bru019, Bru020, Bru021, 
Bru022, Bru023, Bru024, Bru028, Bru030, Bru031 and Bru032 (Hamzeh, personal 
communication). Among those, Bru003, Bru014, Bru015, Bru029 and Bru030 were 
chosen for whole-genome sequencing and will be thus further discussed. 
Fluoroquinolones are sometimes administered as therapy for Brucella infections because 
of their low side effects and high affinity for soft tissues and bones. Moreover, 
fluoroquinolones are able to penetrate cells very efficiently, which made them promising 
candidates in the treatment of intracellular Brucella infections. However, due to high 
relapse rates, especially with ciprofloxacin, accompanied with cross-resistance to other 
fluoroquinolones and low bactericidal activity, they are no longer considered as the 
primary choice for treatment (Al- Sibai, 1992; Rolain et al., 2000). Additionally, and due 
to the misuse of this antibiotic, increasing microbial resistance has emerged (Valdezate 
et al., 2010). Alwan et al. (2010) showed that most of the Brucella isolated from food 
products in Lebanon were resistant to ciprofloxacin, which proves resistance was 
emerging in the country. Fluoroquinolone resistance is attributed to several factors 
including efflux pumps and mutations in resistance genes (Turkmani et al., 2007). Efflux 
pumps usually are not specific against one antimicrobial agent and confer multidrug 
resistance. Among them, the NorMI has a homolog in B. melitensis and has been 
functionally characterized as belonging to the MATE family of toxic compounds and 
multidrug exclusion. NorMI efflux pumps are linked to norfloxacin and ciprofloxacin 
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resistance and were detected in the sequenced genomes (Braibant et al., 2002), 
explaining the resistance against ofloxacin and ciprofloxacin. Another factor could be 
mutations in the quinolone-resistance determining regions of gyrA, gyrB, parC, and 
parE genes encoding DNA gyrase subunit A, DNA gyrase subunit B, DNA 
topoisomerase IV subunit A, and DNA topoisomerase IV subunit B respectively 
(Valdezate et al., 2010). These four genes were detected in the sequenced genomes as 
well, and we further compared their sequences in our isolates to those of reference strain 
B. melitensis 16M to scan for possible mutations linked to fluoroquinolone resistance. 
The B. melitensis gyrA, gyrB, parC and parE gene sequences were downloaded from the 
NCBI gene database with the following accession numbers: BME_RS04405, 
BME_RS09030, BME_RS06035 and BME_RS13510. Bru029, which was the only 
sequenced isolate resistant to ciprofloxacin, showed no mutations in parC, parE or gyrB 
with sequences detected being similar to those of B. melitensis str. 16M downloaded 
from NCBI. These results were similar to results reported by Valdezate et al. (2010), 
where mutations were not detected in any of the above mentioned genes. Based on this, 
resistance to fluoroquinolones in the sequenced isolates couldn’t be attributed to 
mutations in the parC, parE, or gyrB genes but rather possibly to the overexpression of 
the NORMI efflux pump.   
On the other hand, 42% of isolates in this study were resistant to co-trimoxazole 
(trimethoprim and sulfonamide) (Hamzeh, personal communication).  Co-trimoxazole 
has offered successful treatment for certain patients and is the drug of choice when 
tetracyclines cannot be used such as in young children and pregnancy. However, 
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problems were encountered in therapy in the past such as high relapse rates and 
resistance reaching 29% among blood samples of B. melitensis isolated from a total of 
160 patients in Saudi Arabia, which shed light on the emerging resistance against co-
trimoxazole in the Middle East (Memish et al., 2000; Roushan et al., 2006). Co-
trimoxazole resistance has been linked to the presence of Resistance-Nodulation-Cell 
division (RND) efflux pumps that extrude trimethoprim, sulfonamides and other drugs 
as well (Lister et al., 2009), which were detected in all sequenced genomes. In 
association with the bacterial outer membrane, these pumps extrude drugs to the external 
membrane instead of the periplasm so that antimicrobial compounds can’t re-enter 
(Nikaido, 1996; Nikaido & Takatsuka, 2009). Co-trimoxazole resistance accordingly 
could be attributed to the overexpression of RND efflux pumps. RND efflux pumps in 
Brucella conferred multidrug resistance to several antibiotics including co-trimoxazole 
(Martin et al., 2009). Similar results were reported for other organisms as well, as in 
Burkholderia pseudomallei, where trimethoprim resistance was also linked to efflux 
systems, whereas in E. coli and Haemophilus influenzae mutations in the dihydrofolate 
reductase genes and sulfonamide resistance genes sul1 and sul2 caused trimethoprim 
resistance, respectively (Mohd-Zain et al., 2013; Podnecky et al., 2013).  
5.2.3. Detection of prophages 
Acquisition of VFs (virulence factors), toxins, genetic diversity and genomic evolution 
are all the outcome of phage integration into bacterial genomes mediated by horizontal 
gene transfer (Varani et al., 2013). Enzymes important for bacterial pathogenesis and 
proteins involved in adhesion and invasion might also be carried by phages (Boyd & 
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Brussow, 2002). A total of 38 prophage-associated regions were detected in our isolates 
ranging in size between 6.1 and 60.4kb.  Each isolate contained up to three prophages, 
with two being commonly detected: an intact 13.7kb phage (Paraco_vB_Pmas) and an 
incomplete 17.4kb phage (Acantho_moumouvirus). The Acantho_moumouvirus phage 
was similar to that detected in B. abortus bv. 1 (Hammerl et al., 2016). However, little is 
known about prophages and mobile genetic elements in Brucella since many prophages 
were lost during its evolution from a soil to a mammalian pathogen, and therefore, these 
aspects should be better targeted to understand their role in pathogenesis (Delrue et al., 
2004; Hammerl et al., 2016). 
5.2.4. Detection of CRISPRs 
The CRISPR-Cas system in bacteria is responsible for protection from foreign DNA or 
RNA that comes from viruses or mobile genetic elements (Barrangou et al., 2007; Hale 
et al., 2009). Spacers with unique sequences coming from viral origin separate between 
short repeated sequences and hence act against the viruses (Bolotin et al., 2005; Pourcel 
et al., 2005). The more the spacers, the more viruses the CRISPRs can recognize and act 
against (Rath et al., 2015). One possible CRISPR structure was detected in each of the 
sequenced genomes of length 82bp and having one spacer, and this result indicated that 
Brucella might have acquired resistance against phages and therefore have become more 
pathogenic in the process. These findings can be correlated with a recent study also 
reporting the detection of possible CRISPRS in Brucella genomes (Chiliveru et al., 
2015). Moreover, a diguanylate cyclase (a CRISPR-related protein) was also detected in 
some Brucella genomes and this augments the fact that a CRISPR system might actually 
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exist (Chiliveru et al., 2015). This finding was consistent with our results as well, with 
all sequenced isolates having a diguanylate cyclase. This further emphasizes a possible 
link between CRISPR systems and pathogenicity, which needs to be further investigated 
in Brucella to better understand their role.  
5.2.5. Detection of genomic islands 
Using Islandviewer3, we identified a number of hypothetical proteins in GIs, in addition 
to several LPS related genes. Genomic islands (GIs) are clusters of genes acquired by 
bacteria through horizontal gene transfer and some encode factors such as VFs, 
antibiotic resistance genes, and metabolic factors that improve the fitness of the 
corresponding organism. Certain strains of bacteria can be transformed from non-
pathogenic to pathogenic through the acquisition of GIs which are also targeted to study 
polymorphism and evolution among different strains (Dobrindt et al., 2004; Hacker and 
Kaper, 2000). With respect to Brucella, it was thought that the acquisition of GIs helped 
in its evolution from a soil to an intracellular mammalian bacterium and in withstanding 
harsh environmental conditions (Rajashekara et al., 2008). Most proteins encoded on 
Brucella GIs are hypothetical, however, some encoded potential virulence factors such 
as: virB locus, genes involved in LPS synthesis, glycosyltransferases, Omp25, 
exonuclease, and adhesin were also detected on these gene clusters (Delrue et al., 2004; 
Marchesini et al., 2004; O’Callaghan et al., 1999; Rajashekara et al., 2008). Rajashekara 
et al. (2004) revealed the presence of nine GIs in Brucella. GI-2 was also found to be 
important for virulence in B. melitensis and carrying LPS related genes and wboA and 
wboB glycosyltransferases, loss or deletion of which led to a change from smooth to 
64 
 
 
rough strains and hence attenuation (Mancilla et al., 2011; Rajashekara et al., 2008). 
However, a deletion of GI-1, 5, or 6 did not cause any change in virulence or growth and 
hence not involved in pathogenesis (Rajashekara et al., 2008). Among the elements 
detected in all sequenced genomes in this study were: per, gmd, wboA, wboB, wbkC, and 
wbkA encoding for perosamine synthetase, GDP-mannose 4-6 dehydratase, 
glycosyltransferases, formyltransferase, and mannosyltransferase, respectively. 
Previously it was shown that these genes became part of GIs after the transposases 
splitting up the original locus of LPS related genes on chromosome I and flanking it with 
ISBm1 insertion sequences, and thus transforming it from a commensal soil bacterium to 
a virulent intracellular pathogen (Haag et al., 2010; Mancilla, 2011). Moreover, 
exonuclease involved in base excision repair and protection from oxidative damage, was 
carried on GIs detected in Bru013, Bru014, Bru015, Bru029 and Bru035, while outer 
membrane proteins were found on GIs of Bru008, Bru014, Bru015, Bru026, Bru029 
which was similar to results reported by Rajashekara et al. (2008) where outer 
membrane proteins were also detected on GIs. In addition, Bru015 carried components 
of the virB locus, coding for the T4SS, one of the most important VFs in Brucella, which 
was consistent with a previous report which revealed that T4SS components could be 
acquired by horizontal gene transfer in Brucella (Baron et al., 2002). Brucella had 
unique GI regions not harbored by its close ancestor Ochrobactrum, which indicated that 
this acquisition was after diverging from its common ancestor and was mediated by 
lateral transfer and after interacting with soil or gut bacteria (Wattam et al., 2009). 
Brucella is ingested through contaminated foods and milk and is deposited in fecal 
65 
 
 
discharges, with the opportunity to interact and acquire virulence determinants from gut 
bacteria. Although it is an intracellular bacterium, virulence determinants such as LPS, 
were acquired through horizontal gene transfer, and thus enhancing its survival in 
macrophages (Pei et al., 2008). Our findings suggest that virulence determinants 
detected in the studied isolates could be attributed to GI acquisition based on the 
detection of LPS and T4SS related components, which collectively enhance the 
organism’s fitness and survival, rendering it more pathogenic.  
5.2.6. Detection of insertion sequences 
Using IS Finder we identified IS3, ISL3, IS481, IS5, IS66, and IS110 in the sequenced 
isolates. Insertion sequences (ISs) belong to the family of autonomous transposable 
elements, playing a role in genomic diversity and virulence. This leads to antibiotic 
resistance in some instances through affecting the gene expression of efflux systems, or 
attenuating a pathogenic organism as a result of an interruption in a virulence gene 
(Olliver et al., 2005; Wolter et al., 2004). Moreover, genomic rearrangements caused by 
IS elements include deletions, inversions and duplications (Iguchi et al., 2006).  Using IS 
IS711 was detected in all sequenced genomes, which is one of the most important ISs in 
Brucella being specific for the genus. Its number also varies between different species 
and as a result was targeted in molecular typing to differentiate the species. Its 
variability is based on the number of copies where it varies in different species from 
seven copies usually found in B. melitensis, B. abortus, and B. suis to more than 30 in B. 
ovis and B. ceti (Ocampo-Sosa & Garcia-Lobo, 2008). In B. abortus the IS711 is 
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responsible for attenuating the RB51 strain by interrupting the wboA gene involved in 
LPS O-side chain synthesis (Audic et al., 2011; Vemulapalli et al., 2004).  
5.2.7. Phylogenetic analysis 
Phylogenetic analysis clustered the sequenced isolates separately from reference strains 
including strains 16M, ATCC 23457, 63/9, Ether, NI, M28 and M5-90 isolated from 
USA, India, Italy, Mongolia, and China respectively (Tan et al., 2015).  Isolates Bru003, 
Bru015, Bru035 were clustered together, while the remaining were distributed in four 
clades and were distantly positioned from Bru003, Bru015 and Bru034 but closer to 
reference strains 16M and Ether. Since Phylosift is based on concatenated alignment of 
37 core genes of a genome, we performed a comparative analysis between the different 
genomes and the reference strains on RAST to explain this divergence.  Recent studies 
showed that B. melitensis strain ATCC23457 and str. 63-9 were closely related to each 
other and clustered in the same clade, same as str. 16M and Ether based on the 
concatenated alignment of their core genes and on SNPs (Azam et al., 2016; Kay et al., 
2014). When we compared these two pairs (ATCC23457 and 63-9; 16M and Ether) of 
reference genomes on RAST, the main sequence divergence was due to mobile 
elements, hypothetical proteins and phage-related proteins. The core genomes were 
highly conserved, which was consistent with the clustering of both in the same clade. 
Moreover, a comparative analysis was done between reference strains M28 and M5-90 
(Wang et al., 2011), where it was found that M28 is the parent strain of M5-90 with the 
latter being an attenuated version of M28 strain and both exhibiting little divergence. 
Comparing those two strains revealed that divergence was linked to virulence 
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determinants including: cold shock proteins, flagellar genes, respiratory nitrate 
reductase, ABC transporters and some efflux pumps. This was consistent with previous 
reports that M28 was more virulent than M5-90 in spite of the close relatedness. This 
comparative analysis allowed us to better understand the phylogeny of the sequenced 
isolates. So far, few studies have targeted the whole-genome based phylogenetic 
relatedness of B. melitensis strains especially in the Middle East, due to the limited 
number of available full genomes deposited in databases (Tan et al., 2015). Therefore, 
more studies should be done to accurately interpret those findings.  
Through whole-genome sequencing we were able to study the pathogenomics 
characteristics of the clinical B. melitensis isolates used in this study, and further explore 
its pathogenicity and resistance mechanisms in order to identify the emerging cases in 
Lebanon and importance of controlling it before it becomes a pandemic.  
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Chapter Six 
CONCLUSION 
In summary, and to our best knowledge, this is the first study in Lebanon focusing on 
the whole-genome sequencing of Brucella isolated from clinical samples. PCR-RFLP of 
omp31 and omp2a genes proved useful in detection and identification at the species 
level. It was also more accurate than the Bruce ladder multiplex PCR. Through whole- 
genome sequencing we studied antimicrobial resistance genes, VFs, genomic content 
and structure. Despite the similarities in VFs and gene content, differences were detected 
in resistance patterns, prophages, ISs, GIs and VFs carried on GIs. Our findings point to 
the importance of implementing control and prevention measures in order to limit 
Brucella infections in the future and shed light on importance of whole-genome 
sequencing and its future possibility to become a routine diagnostic tool utilized in labs 
worldwide. Further studies will be required to understand the pandemic status in 
Lebanon. In addition, the role of mobile genetic elements in virulence and genetic 
diversity of Brucella in Lebanon should be further investigated. 
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ANNEX 
 
Figure 1. Circular map of Bru003 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 2. Circular map of Bru008 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 3. Circular map of Bru010 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 4. Circular map of Bru013 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 5. Circular map of Bru014 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 6. Circular map of Bru015 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 7. Circular map of Bru018 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 8. Circular map of Bru025 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 9. Circular map of Bru026 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 10. Circular map of Bru027 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 11. Circular map of Bru029 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 12. Circular map of Bru030 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 13. Circular map of Bru034 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 14. Circular map of Bru035 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 15. Circular map of Bru036 genome. From outside to inside, the tracks represent: 
Forward coding sequence (CDS) (red); reverse CDS (blue); tRNAs (green); G+C plot ; 
G+C skew (black above average and grey below average). DNAPlotter (Carver et al, 
2009) was used to generate this image. 
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Figure 16. Circular map of Bru003 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru003 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 17. Circular map of Bru008 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru008 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 18. Circular map of Bru010 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru010 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 19. Circular map of Bru013 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru013 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 20. Circular map of Bru014 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru014 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 21. Circular map of Bru015 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru015 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 22. Circular map of Bru018 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru018 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 23. Circular map of Bru025 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru025 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 24. Circular map of Bru026 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru026 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 25. Circular map of Bru027 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru027 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 26. Circular map of Bru029 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru029 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 27. Circular map of Bru030 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru030 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 28. Circular map of Bru034 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru034 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 29. Circular map of Bru035 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru035 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
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Figure 30. Circular map of Bru036 compared with B. melitensis str. 16M reference 
genome. From outside to inside the rings represent: Bru036 coding DNA sequence 
(CDS) on the forward and reverse strand (blue), B. melitensis 16M chromosome 1 and 2 
Blast results (light pink and light green) representing the positions covered by the 
BLASTN alignment, G+C content (black), G+C positive skew (green) and G+C 
negative skew (purple). CGview Server V 1.0 (Grant & Stothard, 2008) was used to 
construct this image.  
 
 
 
 
